Keywords: mixed, reaction, astrazeneca, acquisition, reactions, suprise, decision

Mixed reaction to AstraZeneca acquisition

Article | 30 April 2007

Print This

Reactions to AstraZeneca's suprise decision to buy US drugmaker MedImmune for $15.6 billion have been mixed, with many thinking that the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in